Depocyt Suspension For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

DepoCyt: Suspension for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CYTARABINE LIPOSOMAL (sye TARE a been LIP oh som al) is a chemotherapy drug that is given into the spinal fluid. It is used to treat lymphoma in the fluid surrounding the brain.

In-Depth Information
Select a Medication

Depocyt 50mg/5ml Suspension for Injection

NDC: 539050331
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Carcinomatous Meningitis

Depocyt 50mg/5ml Suspension for Injection

Reported Side Effects for Depocyt 50mg/5ml Suspension for Injection

Rapid Heart Rate Incidence:
<9.0%*
Severity: MODERATE
Onset: RAPID
Retaining Urine Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Fainting Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Hemorrhoids Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
2.0-3.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
3.0-5.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
3.0-7.0%*
Severity: MILD
Onset: DELAYED
Nerve Pain Incidence:
3.0-12.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
6.0-15.0%*
Severity: MODERATE
Onset: EARLY
Increased Blood Sugar Incidence:
6.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
6.0-18.0%*
Severity: MILD
Onset: DELAYED
Low Potassium Levels Incidence:
7.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
7.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Uncontrolled Urination Incidence:
7.0-9.0%*
Severity: MODERATE
Onset: EARLY
Cough Incidence:
7.0-9.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
8.0-18.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
8.0-18.0%*
Severity: MODERATE
Onset: RAPID
Difficulty Swallowing Incidence:
8.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
9.0-15.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
9.0-11.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
9.0-15.0%*
Severity: MILD
Onset: EARLY
Hypoesthesia Incidence:
10.0-12.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
10.0-40.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
10.0-36.0%*
Severity: MODERATE
Onset: DELAYED
Distressed Incidence:
10.0-15.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
10.0-12.0%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
11.0-24.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
11.0-18.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Memory Incidence:
12.0-14.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
12.0-18.0%*
Severity: MODERATE
Onset: DELAYED
Tiredness Incidence:
12.0-16.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
12.0-27.0%*
Severity: MILD
Onset: EARLY
Dehydration Incidence:
13.0-18.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
14.0-18.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
18.0-21.0%*
Severity: MILD
Onset: EARLY
Inflamed Brain Incidence:
19.0-30.0%*
Severity: SEVERE
Onset: EARLY
Convulsions Incidence:
20.0-21.0%*
Severity: SEVERE
Onset: DELAYED
Back Pain Incidence:
21.0-24.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
24.0-25.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
25.0-27.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
32.0-45.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
33.0-44.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
33.0-36.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
33.0-46.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
52.0-56.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with DepoCyt

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5